Compare Flux Power Holdings Inc (FLUX) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flux Power Holdings Inc vs Zimmer Biomet Holdings Inc — how do they compare? Flux Power Holdings Inc trades at $0.47 (market cap $9.97M), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 1700.1× Flux Power Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while Flux Power Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Flux Power Holdings Inc for 20 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| FLUX | ZBH | |
|---|---|---|
Market Cap | $9.97M | $16.95B |
Volume | 817,320 | 2,505,240 |
Sector | Industrials | Health |
52-Week High | $6.66 | $103.98 |
52-Week Low | $0.41 | $79.58 |
Typical Hold Time | 20 Days | 89 Days |
Enterprise Value | $18.18M | $24.02B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLUX trades at $0.461, down 5.96% today, amid a bearish technical signal and weak earnings. Revenue fell to $42M in 2026 with a net loss of $7M, though the P/S ratio of 0.22 suggests undervaluation. The company rejected an unsolicited acquisition proposal from Solidion Technology in October 2026, adding uncertainty. Analyst consensus remains unanimously bullish with 6 buy ratings, contrasting with negative profitability metrics like a -17.68% net income margin.
The outlook is mixed: strong analyst support and low valuation multiples offer potential upside if execution improves, but persistent losses, declining revenue, and acquisition resistance pose significant risks. Investors should weigh the bullish sentiment against fundamental weaknesses and recent volatility.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% on the day, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $2.07, exceeding expectations, and maintains a solid gross profit margin of 69.87%. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated. Analyst consensus is a 'Buy' with a $103.11 price target, indicating potential upside from current levels.
The outlook for ZBH is cautiously optimistic, supported by earnings momentum and a diversified medical technology portfolio. Key risks include rising debt levels, with debt-to-asset ratio increasing to 32.57% in 2025, and competitive pressures in the healthcare sector. Institutional ownership trends show continued interest, but investors should monitor margin sustainability and capital expenditure efficiency.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Flux Power Holdings Inc
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
